Amandine BASTIN – CMFA/FATHBeyond metabolism: Disrupting PHGDH protein–protein interactions as a therapeutic strategy in colorectal cancerRachel DUBOIS – CMFA Design, synthesis and in vitro pharmacological evaluation of new inhibitors of the CX- system, the cystine/gutamate exchangerDavid NAVARRO SANAGUSTIN – REMA/BPBLImpact of obesity on the metastatic potential of ovarian cancer toward the

Randy BUZISA MBUKU – TFAR FACM/NMSK (IREC)Therapeutic innovation in PJI: A biofilm-disrupting and drug-delivering hydrogel incorporating an enzymatic cocktailPromotor: Prof. Olivier CornuCo-promotor: Prof. Françoise Van BambekeRelated publications :•    Buzisa Mbuku, R, Poilvache H, Maigret L, Vanbever R, Van Bambeke F, Cornu O.

Adrien ALLEGRO – MIRO/FATHClinical and experimental evaluation of MitoQ for the prevention of triple negative breast cancer metastasis (WinQ)Alexandra ARCOS-ORTIZ – MNUTEffects of Parabacteroides on host mesolimbic brain activity during reward food intakeLou-Anne BEGHIN – CMFA/FATHExploiting tumor metabolic vulnerabilities to develop innovative anticancer drugsSarah HUBEAU – CMFAStudy of the activ

Dr Alexandre GOBERTPostdoctoral researcher - CMFA, LDRI, UCLouvainInvestigating ACSL4 inhibition and substrate specificity: a pathway to targeting ferroptosis-related neurodegenerative diseasesRelated publications:Charnelle E, Gobert A, Marteau R, et al. Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties. J Med Chem.